The cerebello-hypothalamic-pituitary-adrenal axis dysregulation hypothesis in depressive disorder

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 779-783

  Schutter, Dennis J L G ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR;

AMYGDALOID NUCLEUS; ARTICLE; CEREBELLUM; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; NEUROANATOMY; PARAVENTRICULAR THALAMIC NUCLEUS; PREFRONTAL CORTEX; STRESS;

CEREBELLUM; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MODELS, THEORETICAL; PITUITARY-ADRENAL SYSTEM;

EID: 84869092285     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.08.027     Document Type: Article

References (43)

1. Gorwood P. Restoring circadian rhythms: a new way to successfully manage depression. J Psychopharmacol 2010, 24:15-19.
2. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 2008, 57:531-553.
3. Nesse R.M. Is depression an adaptation?. Arch Gen Psychiatry 2000, 57:14-20.
4. Carpenter W.T., Bunney W.E. Adrenal cortical activity in depressive illness. Am J Psychiatry 1971, 128:31-40.
5. Cowen P.J. Not fade away: the HPA axis and depression. Psychol Med 2010, 40:1-4.
6. Knorr U., Vinberg M., Kessing L.V., Wetterslev J. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology 2010, 35:1275-1286.
7. O'Keane V., Frodl T., Dinan T.G. A review of atypical depression in relation to the course of depression and changes in HPA axis organization. Psychoneuroendocrinology 2012, 10.1016/j.psyneuen.2012.03.009.
8. Thomson F., Craighead M. Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem Res 2008, 33:691-707.
9. De Winter R.F., van Hemert A.M., DeRijk R.H., Zwinderman K.H., Frankhuijzen-Sierevogel A.C., Wiegant V.M., et al. Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology 2003, 28:140-147.
10. Sorensen P.S., Gjerris A., Hammer M. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. J Neurol Neurosurg Psychiatry 1985, 48:50-57.
11. Rubin R.T., Mandell A.J., Crandall P.H. Corticosteroid responses to limbic stimulation in man: localization of stimulus sites. Science 1966, 153:767-768.
12. Sapolsky R.M., Krey L.C., McEwen B.S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA 1984, 81:6174-6177.
13. Sánchez M.M., Young L.J., Plotsky P.M., Insel T.R. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 2000, 20:4657-4668.
14. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991, 12:118-134.
15. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001, 178:200-220.
16. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1201-1213.
17. Hamilton J.P., Etkin A., Furman D.J., Lemus M.G., Johnson R.F., Gotlib I.H. Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of baseline activation and neural response data. Am J Psychiatry 2012, 10.1176/appi.ajp. 2012.11071105.
18. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 1993, 13:3839-3847.
19. Bellebaum C., Daum I. Cerebellar involvement in executive control. Cerebellum 2007, 6:184-192.
20. Schutter D.J.L.G., van Honk J. The cerebellum on the rise in human emotion. Cerebellum 2005, 4:290-294.
21. Stoodley C.J., Schmahmann J.D. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 2010, 46:831-844.
22. Hoppenbrouwers S.S., Schutter D.J.L.G., Fitzgerald P.B., Chen R., Daskalakis Z.J. The role of the cerebellum in the pathophysiology and treatment of neuropsychiatric disorders: a review. Brain Res Rev 2008, 59:185-200.
23. Schmahmann J.D., Sherman J.C. The cerebellar cognitive affective syndrome. Brain 1998, 121:561-579.
24. Schmahmann J.D., Weilburg J.B., Sherman J.C. The neuropsychiatry of the cerebellum - insights from the clinic. Cerebellum 2007, 6:254-267.
25. Schutter D.J.L.G., van Honk J. The cerebellum in emotion regulation: a repetitive transcranial magnetic stimulation study. Cerebellum 2009, 8:28-34.
26. Schutter D.J.L.G., van Honk J., d'Alfonso A.A.L., Peper J.S., Panksepp J. High frequency repetitive transcranial magnetic over the medial cerebellum induces a shift in the prefrontal electroencephalography gamma spectrum: a pilot study in humans. Neurosci Lett 2003, 336:73-76.
27. Schutter D.J.L.G., Enter D., Hoppenbrouwers S.S. High-frequency repetitive transcranial magnetic stimulation to the cerebellum and implicit processing of happy facial expressions. J Psychiatry Neurosci 2009, 34:60-65.
28. Fitzgerald P.B., Laird A.R., Maller J., Daskalakis Z.J. A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 2008, 29:683-695.
29. De Bellis M.D., Kuchibhatla M. Cerebellar volumes in pediatric maltreatment- related posttraumatic stress disorder. Biol Psychiatry 2006, 60:697-703.
30. Escalona P.R., MacDonald W.M., Doraiswamy P.M., Fiegel G.S., Boyko O.B., Ellinwood E.R., et al. Reduction of cerebellar volume in major depression: a controlled MRI study. Depression 1993, 1:156-158.
31. Schutter D.J.L.G., Koolschijn P.C., Peper J.S., Crone E.A. The cerebellum link to neuroticism: a volumetric MRI association study in healthy volunteers. PLoS One 2012, 7:e37252.
32. Bolbecker A.R., Hong S.L., Kent J.S., Forsyth J.K., Klaunig M.J., Lazar E.K., et al. Paced finger-tapping abnormalities in bipolar disorder indicate timing dysfunction. Bipolar Disord 2011, 13:99-110.
33. Daban C., Vieta E., Mackin P., Young A.H. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 2005, 28:469-480.
34. Zhu J.N., Yung W.H., Kwok-Chong Chow B., Chan Y.S., Wang J.J. The cerebellar- hypothalamic circuits: potential pathways underlying cerebellar involvement in somatic-visceral integration. Brain Res Rev 2006, 52:93-106.
35. Dietrichs E. Cerebellar autonomic function: direct hypothalamocerebellar pathway. Science 1984, 223:591-593.
36. Haines D.E., Dietrichs E., Mihailoff G.A., McDonald E.F. The cerebellar - hypothalamic axis: basic circuits and clinical observations. Int Rev Neurobiol 1997, 41:83-107.
37. Lu J.H., Mao H.N., Cao B.B., Qiu Y.H., Peng Y.P. Effect of cerebellohypothalamic glutamatergic projections on immune function. Cerebellum 2012, 10.1007/s12311-012-0356-8.
38. Wang F., Cao B.B., Liu Y., Huang Y., Peng Y.P., Qiu Y.H. Role of cerebellohypothalamic GABAergic projection in mediating cerebellar immunomodulation. Int J Neurosci 2011, 121:237-245.
39. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996, 17:187-205.
40. Nemeroff C.B., Owens M.J. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis. CNS Spectr 2004, 9:23-31.
41. Gallagher P., Malik N., Newham J., Young A.H., Ferrier I.N., Mackin P. Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev 2008, 1:CD005168.
42. Bolwig T.G. How does electroconvulsive therapy work? Theories on its mechanism. Can J Psychiatry 2011, 56:13-18.
43. Schutter D.J.L.G. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham- controlled designs: a meta-analysis. Psychol Med 2009, 39:65-75.